FDA Recall United States Terminated Historical recordClass II
Professional Complementary Health Formulas, LLC
- Product
- Inositol packaged in white plastic bottle with UPC 406511156…
- Published
- February 8, 2023
- Distribution
- Nationwide
Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA, WHO, and other public sources. It is an independent information service, not a medical provider, and not a substitute for professional medical advice or your local public health department's own guidance.
Please review the following before continuing:
Policy version 2026-07-21, effective July 21, 2026.
United States
TerminatedClass II
Product recalled due to undeclared niacin.
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Vitamin B Complex packaged in white plastic bottle labeled in part, "***PROFESSIONAL FORMULAS COMPLEMENTARY HEALTH Vitamin B Complex DIETARY SUPPLEMENT 60 Capsules***Supplement Facts Serving Size: One Capsule***Vitamin B1 (as thiamine Hcl) 80mg 6667% Vitamin B2 (as riboflavin) 80 mg 6154% Vitamin B3 (as niacinamide) 80 mg NE 500% Vitamin B6 (as pyridoxine HCl) 80 mg 4706% Folic acid 667 mcg DFE 167% Vitamin B12 (as cyanocobalamin) 80 mcg 3333% Biotin 300 mcg 1000% Vitamin B5 (as calcium pantothenate) 80 mg 1600% Choline (as bitartrate) 80 mg 15%***Professional Formulas PO Box 2034, Lake Oswego, OR 97035 Recommended Dosage: As a nutritional supplement, take one capsule, or as directed by your healthcare professional***FOR PROFESSIONAL USE ONLY" | Not published in this source record | 299 bottles | Lot 1092715 |
This recall shares FDA event ID 91377 with 1 other product entry in Public Health Trace.
FDA Recall United States Terminated Historical recordClass II
Responsible company: Professional Complementary Health Formulas, LLC
FDA Recall United States Terminated Historical recordClass II
FDA Recall United States Terminated Historical recordClass II
A map highlighting the states named in the source's distribution description.
Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.
| State | Distributed |
|---|---|
| New York | 1 |
| Oregon | 1 |
| Pennsylvania | 1 |
| Utah | 1 |
| Wisconsin | 1 |
| Wyoming | 1 |
States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.
View FDA enforcement record -- the specific openFDA record this summary was built from.
No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.